Rabeprazole Sulfone-d3 is a deuterated form of rabeprazole sulfone, which is a proton pump inhibitor (PPI) used primarily for the treatment of gastroesophageal reflux disease (GERD) and other conditions related to excessive stomach acid production. The deuterated version, indicated by the "d3" in its name, contains three deuterium atoms, which are isotopes of hydrogen. This modification can enhance the stability and metabolic tracking of the compound in pharmacokinetic studies. Rabeprazole sulfone itself is characterized by its ability to irreversibly inhibit the H+/K+ ATPase enzyme in the gastric parietal cells, leading to decreased gastric acid secretion. The compound is typically administered orally and is known for its rapid onset of action and relatively short half-life. In terms of physical properties, it is generally a white to off-white powder, soluble in organic solvents, and exhibits stability under standard storage conditions. Its use in research often focuses on understanding drug metabolism and the pharmacological effects of PPIs.

Rabeprazole Sulfone-d3

1330261-33-0: Rabeprazole Sulfone-d3 is a deuterated form of rabeprazole sulfone, which is a proton pump inhibitor (PPI) used primarily for the treatment of gastroesophageal reflux disease (GERD) and other conditions related to excessive stomach acid production. The deuterated version, indicated by the "d3" in its name, contains three deuterium atoms, which are isotopes of hydrogen. This modification can enhance the stability and metabolic tracking of the compound in pharmacokinetic studies. Rabeprazole sulfone itself is characterized by its ability to irreversibly inhibit the H+/K+ ATPase enzyme in the gastric parietal cells, leading to decreased gastric acid secretion. The compound is typically administered orally and is known for its rapid onset of action and relatively short half-life. In terms of physical properties, it is generally a white to off-white powder, soluble in organic solvents, and exhibits stability under standard storage conditions. Its use in research often focuses on understanding drug metabolism and the pharmacological effects of PPIs.

CAS 1330261-33-0

Rabeprazole Sulfone-d3

Rabeprazole EP Impurity A-d3 (Rabeprazole USP Related Compound D-d3, Rabeprazole Sulfone-d3)

Ref: 4Z-R-2035